QURE uniQure NV

  1. Stocks
  2. Healthcare
  3. NASDAQ: QURE

Price (delayed)

$8.335

Market cap

$404.66M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$6.21

Enterprise value

$704.1M

uniQure is delivering on the promise of gene therapy - single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline ...

Highlights
The quick ratio is up by 41% year-on-year and by 6% since the previous quarter
The net income has dropped by 89% year-on-year but it rose by 3.8% since the previous quarter
The company's EPS has shrunk by 86% YoY but it rose by 4% QoQ
The gross profit has plunged by 164% from the previous quarter and by 101% YoY
The gross margin has dropped by 154% since the previous quarter and by 108% year-on-year
Sector: Healthcare
Industry: Biotechnology
Peers: AMGN SGMO BMRN BLUE

Key stats

What are the main financial stats of QURE
Market
Shares outstanding
48.55M
Market cap
$404.66M
Enterprise value
$704.1M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.72
Price to sales (P/S)
21.22
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
37.05
Earnings
Revenue
$19M
EBIT
-$238.99M
EBITDA
-$226.99M
Free cash flow
-$135.36M
Per share
EPS
-$6.21
Free cash flow per share
-$2.8
Book value per share
$3.07
Revenue per share
$0.39
TBVPS
$14.16
Balance sheet
Total assets
$770.05M
Total liabilities
$623.3M
Debt
$542.5M
Equity
$146.75M
Working capital
$532.53M
Liquidity
Debt to equity
3.7
Current ratio
9.39
Quick ratio
8.92
Net debt/EBITDA
-1.32
Margins
EBITDA margin
-1,194.5%
Gross margin
-7.5%
Net margin
-1,562.2%
Operating margin
-1,383.6%
Efficiency
Return on assets
-34.8%
Return on equity
-121.6%
Return on invested capital
-26%
Return on capital employed
-33.8%
Return on sales
-1,257.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

QURE stock price

How has the uniQure stock price performed over time
Intraday
-2.74%
1 week
7.69%
1 month
89.43%
1 year
-12.26%
YTD
23.12%
QTD
86.05%

Financial performance

How have uniQure's revenue and profit performed over time
Revenue
$19M
Gross profit
-$1.42M
Operating income
-$262.93M
Net income
-$296.87M
Gross margin
-7.5%
Net margin
-1,562.2%
The gross profit has plunged by 164% from the previous quarter and by 101% YoY
The gross margin has dropped by 154% since the previous quarter and by 108% year-on-year
The net income has dropped by 89% year-on-year but it rose by 3.8% since the previous quarter
The company's revenue has shrunk by 83% YoY but it rose by 20% QoQ

Growth

What is uniQure's growth rate over time

Valuation

What is uniQure stock price valuation
P/E
N/A
P/B
2.72
P/S
21.22
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
37.05
The company's EPS has shrunk by 86% YoY but it rose by 4% QoQ
QURE's P/B is 86% above its last 4 quarters average of 1.5 but 25% below its 5-year quarterly average of 3.7
The equity has shrunk by 64% YoY and by 29% QoQ
The P/S is 112% higher than the last 4 quarters average of 10.3 but 77% lower than the 5-year quarterly average of 95.5
The company's revenue has shrunk by 83% YoY but it rose by 20% QoQ

Efficiency

How efficient is uniQure business performance
The ROA has contracted by 48% YoY but it has grown by 8% from the previous quarter
The return on invested capital has increased by 41% year-on-year and by 21% since the previous quarter
The company's return on sales rose by 25% QoQ
The return on equity has declined by 22% since the previous quarter

Dividends

What is QURE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for QURE.

Financial health

How did uniQure financials performed over time
QURE's total assets is 24% greater than its total liabilities
The total liabilities has soared by 186% YoY
The quick ratio is up by 41% year-on-year and by 6% since the previous quarter
The equity has shrunk by 64% YoY and by 29% QoQ
The debt to equity is up by 45% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.